U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07272330) titled 'A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects' on Nov. 26.
Brief Summary: This Phase I clinical trial will investigate the relative bioavailability between two formulations of HRS-1893 tablets and the influence of food on the drug's pharmacokinetics in healthy adult participants. The safety and tolerability of HRS-1893 will also be monitored.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Cardiomyopathy
Intervention:
DRUG: HRS-1893 tablet A
Specified dose on specified days.
DRUG: HRS-1893 tablet B
Specified dose on specified days.
Recruitment Sta...